Estimation of the cure rate in Iranian breast cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 12, 2014, Pages 4839-4842

  Rahimzadeh, Mitra ^a   Baghestani, Ahmad Reza ^b   Gohari, Mahmood Reza ^c   Pourhoseingholi, Mohamad Amin ^b  

^a ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Cure rate model; Long term survival analysis

Indexed keywords

ADULT; AGED; BREAST NEOPLASMS; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; IRAN; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; SURVIVAL RATE; TIME; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84904619721     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.12.4839     Document Type: Article

References (28)

1. Abdullah NA, Wan Mahiyuddin WR, Muhammad NA et al (2013). Survival rate of breast cancer patients in Malaysia: a population-based study. Asian Pac J Cancer Prev, 14, 4591-4.
2. Al-Naggar RA, Isa ZM, Shah SA, et al (2009). Eight year survival among breast cancer Malaysian women from University Kebangsaan Malaysia Medical Centre. Asian Pac J Cancer Prev, 10, 1075-8.
3. Arkoob K, Al-Nsour M, Al-Nemry O, Al-Hajawi B (2010). Epidemiology of breast cancer in women in Jordan: patient characteristics and survival analysis. East Mediterr Health J, 16, 1032-8.
4. Asano J, Hirakawa A, Hamada C, et al (2013). Use of Cox's cure model to establish clinical determinants of long-term disease-free survival in neoadjuvant-chemotherapy-treated breast cancer patients without pathologic complete response. Int J Breast Cancer, ???? 354579.
5. Babaee GH, Feyzi A, Keshavarz M (2005). Study effect of various therapeutic and surgery methods on survival rate in breast cancer. J Daneshvar, 59, 19-28 (in Persian).
6. Borges P, Rodrigues J, Balakrishnan N (2012). Correlated destructive generalized power series cure rate models and associated inference with an application to a cutaneous melanoma data. Comput Stat Data Anal, 56, 1703-13.
7. Bray F, McCarron P, Parkin DM (2004). The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res, 6, 229-39.
8. Cancho VG, Louzada-Neto F, Ortega EMM (2013). The Power Series Cure Rate Model: An Application to a Cutaneous Melanoma Data. Communications in Statistics - Simulation and Computation, 42, 586-602.
9. Chen MH, Ibrahim JG, Sinha D (1999). A new Bayesian model for survival data with a surviving fraction. J Am Stat Assoc, 94, 909-19.
10. Cooner F, Banerjee S, Carlin BP, Sinha D (2007). Flexible cure rate modeling under latent activation schemes. J Am Stat Assoc, 102, 560-72.
11. Dickman PW, Hakulinen T (2000). Population-based cancer survival analysis (Statistics in Practice Series). New Jersey, John Wiley.
12. Elmore JG, Armstrong K, Lehman CD, Fletcher SW (2005). Screening for breast cancer. JAMA, 293, 1245-56.
13. Fouladi N, Amani F, Harghi AS, Nayebyazdi N (2011). Five year survival of women with breast cancer in Ardabil, north-west of Iran. Asian Pac J Cancer Prev, 12, 1799-801.
14. Gakwaya A, Kigula-Mugambe JB, Kavuma A, et al (2008). Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer, 99, 63-7.
15. Haghighat S, Akbari ME, Ghaffari S, Yavari P (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8.
16. Hoerger TJ, Ekwueme DU, Miller JW, et al (2011). Estimated effects of the national breast and cervical cancer early detection program on breast cancer mortality. Am J Prev Med, 40, 397-404.
17. Lee JH, Yim SH, Won YJ, et al (2007). Population-based breast cancer statistics in Korea during 1993_2002: incidence, mortality, and survival. J Korean Med Sci, 22, 11-6.
18. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran Metropolis: The first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med, 12, 15-23.
19. Moore MA, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pac J Cancer Prev, 11 Suppl, 17-32.
20. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91.
21. Najafi B, Anvari S, Roshan ZA (2013).Disease free survival among molecular subtypes of early stage breast cancer between 2001 and 2010 in Iran. Asian Pac J Cancer Prev, 14, 5811-6.
22. Park SK, Kim Y, Kang D, Jung EJ, Yoo KY (2011). Risk factors and control strategies for the rapidly rising rate of breast cancer in Korea. J Breast Cancer, 14, 79-87.
23. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
24. Sadjadi A, Nouraie M, Mohagheghi MA, et al (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359-63.
25. Taghavi A, Fazeli Z, Vahedi M, et al (2012). Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70.
26. Tomohiro A (2007). Bayesian predictive information criterion for the evaluation of hierarchical Bayesian and empirical Bayes models. Biometrika, 94, 443-58.
27. Yaghmayee S, Banihashemi Gh, Ghorbani R (2007). Study survival rate and effective cause om survival rate in women with breast cancer reffred to Semnan hospital in 1991-2002: using Cox regression. J Semnan Univ Med Sci, 9, 111-5 (in Persian).
28. Yakovlev AY, Tsodikov AD (1996). Stochastic Models of Tumor Latency and Their Biostatistical Applications,World Scientific, Singapore, Hackensack, NJ.